It seems to me that the risk (to CM personally, and to the company) of making a public and recorded statement like this, while at the same time being aware that the ALZ trial (already PR'd to report TLD on 12/1) has missed its endpoints, is far too great for most anyone, but especially CM, to make. I think this bodes very well for the outcomes to be reported on 12/1.